메뉴 건너뛰기




Volumn 26, Issue 11, 2011, Pages 3722-3728

Combined vascular effects of HMG-CoA reductase inhibitor and angiotensin receptor blocker in non-diabetic patients undergoing peritoneal dialysis

Author keywords

angiotensin receptor blocker; arterial stiffness; endothelial function; peritoneal dialysis; statin

Indexed keywords

8 ISOPROSTANE; ALBUMIN; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PARATHYROID HORMONE; PHOSPHORUS; ROSUVASTATIN; TRIACYLGLYCEROL; VALSARTAN; VITAMIN D;

EID: 79959720383     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr108     Document Type: Article
Times cited : (26)

References (37)
  • 3
    • 0041318888 scopus 로고    scopus 로고
    • Cardiovascular calcifications in uremic patients: Clinical impact on cardiovascular function
    • London GM. Cardiovascular calcifications in uremic patients: Clinical impact on cardiovascular function. J Am Soc Nephrol 2003; 14: S305-S309
    • (2003) J Am Soc Nephrol , vol.14
    • London, G.M.1
  • 4
    • 0031780541 scopus 로고    scopus 로고
    • Endothelium-dependent vasodilatation is impaired in peritoneal dialysis patients
    • van Guldener C, Janssen MJ, Lambert J et al. Endothelium-dependent vasodilatation is impaired in peritoneal dialysis patients. Nephrol Dial Transplant 1998; 13: 1782-1786
    • (1998) Nephrol Dial Transplant , vol.13 , pp. 1782-1786
    • Van Guldener, C.1    Janssen, M.J.2    Lambert, J.3
  • 5
    • 0030715674 scopus 로고    scopus 로고
    • Altered flow-dependent vasodilatation of conduit arteries in maintenance haemodialysis
    • Joannides R, Bakkali EH, Le Roy F et al. Altered flow-dependent vasodilatation of conduit arteries in maintenance haemodialysis. Nephrol Dial Transplant 1997; 12: 2623-2628
    • (1997) Nephrol Dial Transplant , vol.12 , pp. 2623-2628
    • Joannides, R.1    Bakkali, E.H.2    Le Roy, F.3
  • 6
    • 0033545950 scopus 로고    scopus 로고
    • Impact of aortic stiffness on survival in end-stage renal disease
    • Blacher J, Guerin AP, Pannier B et al. Impact of aortic stiffness on survival in end-stage renal disease. Circulation 1999; 99: 2434-2439
    • (1999) Circulation , vol.99 , pp. 2434-2439
    • Blacher, J.1    Guerin, A.P.2    Pannier, B.3
  • 7
    • 1642561670 scopus 로고    scopus 로고
    • Forearm reactive hyperemia and mortality in end-stage renal disease
    • London GM, Pannier B, Agharazii M et al. Forearm reactive hyperemia and mortality in end-stage renal disease. Kidney Int 2004; 65: 700-704
    • (2004) Kidney Int , vol.65 , pp. 700-704
    • London, G.M.1    Pannier, B.2    Agharazii, M.3
  • 8
    • 0037174372 scopus 로고    scopus 로고
    • Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: A Losartan Intervention for Endpoint Reduction (LIFE) substudy
    • Kjeldsen SE, Dahlof B, Devereux RB et al. Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: A Losartan Intervention for Endpoint Reduction (LIFE) substudy. JAMA 2002; 288: 1491-1498
    • (2002) JAMA , vol.288 , pp. 1491-1498
    • Kjeldsen, S.E.1    Dahlof, B.2    Devereux, R.B.3
  • 9
    • 0027987849 scopus 로고
    • Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
    • Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383-1389
    • (1994) Lancet , vol.344 , pp. 1383-1389
  • 10
    • 1442360727 scopus 로고    scopus 로고
    • A selective angiotensin receptor antagonist, Valsartan, produced regression of left ventricular hypertrophy associated with a reduction of arterial stiffness
    • Suzuki H, Nakamoto H, Okada H et al. A selective angiotensin receptor antagonist, Valsartan, produced regression of left ventricular hypertrophy associated with a reduction of arterial stiffness. Adv Perit Dial 2003; 19: 59-66
    • (2003) Adv Perit Dial , vol.19 , pp. 59-66
    • Suzuki, H.1    Nakamoto, H.2    Okada, H.3
  • 11
    • 34347234760 scopus 로고    scopus 로고
    • Effect of a treatment strategy consisting of pravastatin, vitamin E, and homocysteine lowering on carotid intima-media thickness, endothelial function, and renal function in patients with mild to moderate chronic kidney disease: Results from the Anti-Oxidant Therapy in Chronic Renal Insufficiency (ATIC) Study
    • Nanayakkara PW, van Guldener C, ter Wee PM et al. Effect of a treatment strategy consisting of pravastatin, vitamin E, and homocysteine lowering on carotid intima-media thickness, endothelial function, and renal function in patients with mild to moderate chronic kidney disease: Results from the Anti-Oxidant Therapy in Chronic Renal Insufficiency (ATIC) Study. Arch Intern Med 2007; 167: 1262-1270
    • (2007) Arch Intern Med , vol.167 , pp. 1262-1270
    • Nanayakkara, P.W.1    Van Guldener, C.2    Ter Wee, P.M.3
  • 12
    • 33750103663 scopus 로고    scopus 로고
    • Candesartan, an angiotensin II type-1 receptor blocker, reduces cardiovascular events in patients on chronic haemodialysis-a randomized study
    • Takahashi A, Takase H, Toriyama T et al. Candesartan, an angiotensin II type-1 receptor blocker, reduces cardiovascular events in patients on chronic haemodialysis-a randomized study. Nephrol Dial Transplant 2006; 21: 2507-2512
    • (2006) Nephrol Dial Transplant , vol.21 , pp. 2507-2512
    • Takahashi, A.1    Takase, H.2    Toriyama, T.3
  • 13
    • 49749083154 scopus 로고    scopus 로고
    • Effect of angiotensin receptor blockers on cardiovascular events in patients undergoing hemodialysis: An open-label randomized controlled trial
    • Suzuki H, Kanno Y, Sugahara S et al. Effect of angiotensin receptor blockers on cardiovascular events in patients undergoing hemodialysis: An open-label randomized controlled trial. Am J Kidney Dis 2008; 52: 501-506
    • (2008) Am J Kidney Dis , vol.52 , pp. 501-506
    • Suzuki, H.1    Kanno, Y.2    Sugahara, S.3
  • 14
    • 22344458137 scopus 로고    scopus 로고
    • Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis
    • Wanner C, Krane V, MarzWet al. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 2005; 353: 238-248
    • (2005) N Engl J Med , vol.353 , pp. 238-248
    • Wanner, C.1    Krane, V.2    Marz, W.3
  • 15
    • 0035922441 scopus 로고    scopus 로고
    • Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
    • Brenner BM, Cooper ME, de Zeeuw D et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001; 345: 861-869
    • (2001) N Engl J Med , vol.345 , pp. 861-869
    • Brenner, B.M.1    Cooper, M.E.2    De Zeeuw, D.3
  • 16
    • 0035922447 scopus 로고    scopus 로고
    • Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes
    • Lewis EJ, Hunsicker LG, Clarke WR et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 2001; 345: 851-860
    • (2001) N Engl J Med , vol.345 , pp. 851-860
    • Lewis, E.J.1    Hunsicker, L.G.2    Clarke, W.R.3
  • 17
    • 63849163945 scopus 로고    scopus 로고
    • Rosuvastatin and cardiovascular events in patients undergoing hemodialysis
    • Fellstrom BC, Jardine AG, Schmieder RE et al. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med 2009; 360: 1395-1407
    • (2009) N Engl J Med , vol.360 , pp. 1395-1407
    • Fellstrom, B.C.1    Jardine, A.G.2    Schmieder, R.E.3
  • 18
    • 0346881199 scopus 로고    scopus 로고
    • Renal replacement therapy in patients with diabetes and end-stage renal disease
    • Locatelli F, Pozzoni P, Del Vecchio L. Renal replacement therapy in patients with diabetes and end-stage renal disease. J Am Soc Nephrol 2004; 15 (Suppl 1): S25-S29
    • (2004) J Am Soc Nephrol , vol.15 , Issue.SUPPL. 1
    • Locatelli, F.1    Pozzoni, P.2    Del Vecchio, L.3
  • 19
    • 43749084209 scopus 로고    scopus 로고
    • Hyperglycemia and the pathobiology of diabetic complications
    • Aronson D. Hyperglycemia and the pathobiology of diabetic complications. Adv Cardiol 2008; 45: 1-16
    • (2008) Adv Cardiol , vol.45 , pp. 1-16
    • Aronson, D.1
  • 20
    • 0032588251 scopus 로고    scopus 로고
    • Mechanistic differences of various AT1-receptor blockers in isolated vessels of different origin
    • Morsing P, Adler G, Brandt-Eliasson U et al. Mechanistic differences of various AT1-receptor blockers in isolated vessels of different origin. Hypertension 1999; 33: 1406-1413
    • (1999) Hypertension , vol.33 , pp. 1406-1413
    • Morsing, P.1    Adler, G.2    Brandt-Eliasson, U.3
  • 21
    • 12244290343 scopus 로고    scopus 로고
    • Functional antagonism of different angiotensin II type I receptor blockers in human arteries
    • Wagenaar LJ, Voors AA, Buikema H et al. Functional antagonism of different angiotensin II type I receptor blockers in human arteries. Cardiovasc Drugs Ther 2002; 16: 311-316
    • (2002) Cardiovasc Drugs Ther , vol.16 , pp. 311-316
    • Wagenaar, L.J.1    Voors, A.A.2    Buikema, H.3
  • 22
    • 0035235042 scopus 로고    scopus 로고
    • NKF-K/DOQI Clinical Practice Guidelines for Peritoneal Dialysis Adequacy: Update 2000
    • Peritoneal Dialysis Adequacy Work Group
    • Peritoneal Dialysis Adequacy Work Group. NKF-K/DOQI Clinical Practice Guidelines for Peritoneal Dialysis Adequacy: Update 2000. Am J Kidney Dis 2001; 37: S65-S136
    • (2001) Am J Kidney Dis , vol.37
  • 23
    • 0037116573 scopus 로고    scopus 로고
    • Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: A report of the International Brachial Artery Reactivity Task Force
    • Corretti MC, Anderson TJ, Benjamin EJ et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: A report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002; 39: 257-265
    • (2002) J Am Coll Cardiol , vol.39 , pp. 257-265
    • Corretti, M.C.1    Anderson, T.J.2    Benjamin, E.J.3
  • 24
    • 0042869594 scopus 로고    scopus 로고
    • Utility of automated brachial ankle pulse wave velocity measurements in hypertensive patients
    • Munakata M, Ito N, Nunokawa T et al. Utility of automated brachial ankle pulse wave velocity measurements in hypertensive patients. Am J Hypertens 2003; 16: 653-657
    • (2003) Am J Hypertens , vol.16 , pp. 653-657
    • Munakata, M.1    Ito, N.2    Nunokawa, T.3
  • 25
    • 25444460810 scopus 로고    scopus 로고
    • Low doses of losartan and trandolapril improve arterial stiffness in hemodialysis patients
    • Ichihara A, Hayashi M, Kaneshiro Y et al. Low doses of losartan and trandolapril improve arterial stiffness in hemodialysis patients. Am J Kidney Dis 2005; 45: 866-874
    • (2005) Am J Kidney Dis , vol.45 , pp. 866-874
    • Ichihara, A.1    Hayashi, M.2    Kaneshiro, Y.3
  • 26
    • 33751110214 scopus 로고    scopus 로고
    • Atherosclerosis versus arterial stiffness in advanced renal failure
    • Guerin A, Pannier B, London G. Atherosclerosis versus arterial stiffness in advanced renal failure. Adv Cardiol 2007; 44: 187-198
    • (2007) Adv Cardiol , vol.44 , pp. 187-198
    • Guerin, A.1    Pannier, B.2    London, G.3
  • 27
    • 73249122122 scopus 로고    scopus 로고
    • Assessment of arterial stiffness affected by atorvastatin in coronary artery disease using pulse wave velocity
    • Meng X, Qie L, Wang Y et al. Assessment of arterial stiffness affected by atorvastatin in coronary artery disease using pulse wave velocity. Clin Invest Med 2009; 32: E238
    • (2009) Clin Invest Med , vol.32
    • Meng, X.1    Qie, L.2    Wang, Y.3
  • 28
    • 0033039589 scopus 로고    scopus 로고
    • Distinct and combined vascular effects of ACE blockade and HMG-CoA reductase inhibition in hypertensive subjects
    • Nazzaro P, Manzari M, Merlo M et al. Distinct and combined vascular effects of ACE blockade and HMG-CoA reductase inhibition in hypertensive subjects. Hypertension 1999; 33: 719-725
    • (1999) Hypertension , vol.33 , pp. 719-725
    • Nazzaro, P.1    Manzari, M.2    Merlo, M.3
  • 29
    • 39449084717 scopus 로고    scopus 로고
    • The endothelium as a target in renal diseases
    • Zoccali C. The endothelium as a target in renal diseases. J Nephrol 2007; 20 (Suppl 12): S39-S44
    • (2007) J Nephrol , vol.20 , Issue.SUPPL. 12
    • Zoccali, C.1
  • 30
    • 58149352649 scopus 로고    scopus 로고
    • Accelerated atherosclerotic calcification and Monckeberg's sclerosis: A continuum of advanced vascular pathology in chronic kidney disease
    • McCullough PA, Agrawal V, Danielewicz E et al. Accelerated atherosclerotic calcification and Monckeberg's sclerosis: A continuum of advanced vascular pathology in chronic kidney disease. Clin J Am Soc Nephrol 2008; 3: 1585-1598
    • (2008) Clin J Am Soc Nephrol , vol.3 , pp. 1585-1598
    • McCullough, P.A.1    Agrawal, V.2    Danielewicz, E.3
  • 31
    • 58149457209 scopus 로고    scopus 로고
    • Blockage of the reninangiotensin system attenuates mortality but not vascular calcification in uremic rats: Sevelamer carbonate prevents vascular calcification
    • Tokumoto M, Mizobuchi M, Finch JL et al. Blockage of the reninangiotensin system attenuates mortality but not vascular calcification in uremic rats: Sevelamer carbonate prevents vascular calcification. Am J Nephrol 2009; 29: 582-591
    • (2009) Am J Nephrol , vol.29 , pp. 582-591
    • Tokumoto, M.1    Mizobuchi, M.2    Finch, J.L.3
  • 32
    • 38049033935 scopus 로고    scopus 로고
    • Efficacy of cholesterollowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: A meta-analysis
    • Kearney PM, Blackwell L, Collins R et al. Efficacy of cholesterollowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: A meta-analysis. Lancet 2008; 371: 117-125
    • (2008) Lancet , vol.371 , pp. 117-125
    • Kearney, P.M.1    Blackwell, L.2    Collins, R.3
  • 33
    • 48749092662 scopus 로고    scopus 로고
    • Volume overhydration is related to endothelial dysfunction in continuous ambulatory peritoneal dialysis patients
    • Cheng LT, Gao YL, Qin C et al. Volume overhydration is related to endothelial dysfunction in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 2008; 28: 397-402
    • (2008) Perit Dial Int , vol.28 , pp. 397-402
    • Cheng, L.T.1    Gao, Y.L.2    Qin, C.3
  • 34
    • 40949129221 scopus 로고    scopus 로고
    • Residual renal function-one of the factors associated with arterial stiffness in peritoneal dialysis patients Insight from a retrospective study in 146 peritoneal dialysis patients
    • Huang WH, Chen KH, Hsu CW et al. Residual renal function-one of the factors associated with arterial stiffness in peritoneal dialysis patients. Insight from a retrospective study in 146 peritoneal dialysis patients. Blood Purif 2008; 26: 133-137
    • (2008) Blood Purif , vol.26 , pp. 133-137
    • Huang, W.H.1    Chen, K.H.2    Hsu, C.W.3
  • 35
    • 0025283892 scopus 로고
    • Abnormal endotheliumdependent vascular relaxation in patients with essential hypertension
    • Panza JA, Quyyumi AA, Brush JE Jr. et al. Abnormal endotheliumdependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990; 323: 22-27
    • (1990) N Engl J Med , vol.323 , pp. 22-27
    • Panza, J.A.1    Quyyumi, A.A.2    Brush Jr., J.E.3
  • 36
    • 33947303030 scopus 로고    scopus 로고
    • A review of high-dose statin therapy: Targeting cholesterol and inflammation in atherosclerosis
    • Patel TN, Shishehbor MH, Bhatt DL. A review of high-dose statin therapy: Targeting cholesterol and inflammation in atherosclerosis. Eur Heart J 2007; 28: 664-672
    • (2007) Eur Heart J. , vol.28 , pp. 664-672
    • Patel, T.N.1    Shishehbor, M.H.2    Bhatt, D.L.3
  • 37
    • 0032229826 scopus 로고    scopus 로고
    • Epidemiology of cardiovascular disease in chronic renal disease
    • Foley RN, Parfrey PS, Sarnak MJ. Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 1998; 9: S16-S23
    • (1998) J Am Soc Nephrol , vol.9
    • Foley, R.N.1    Parfrey, P.S.2    Sarnak, M.J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.